FACILITIES
Portugal
Our strategically located facility in central-northern Portugal capitalizes on ideal climate conditions for greenhouse cultivation and offers easy access via major European highways. Spanning 10,000 m², the site includes:
• Five greenhouses with automated environmental controls meeting GACP regulations
• A post-processing and quality control unit compliant with GMP standards
We anticipate receiving our “license to operate” soon, enabling us to execute all production steps from cloning to drying and trimming of flower buds. This will position Grüne Labs to export final products to other European countries. Our facility has ample space to cultivate specific genetics tailored to our clients’ needs and specifications.
Uruguay
Since obtaining our license from the Instituto de Regulación y Control de Cannabis (IRCCA) in 2019, we have operated a state-of the-art indoor Cannabis cultivation and extraction facility in Uruguay. Our license permits cloning, cultivation, harvesting, and drying of Cannabis sativa L. plant material. In 2022, we achieved GMP certification, ensuring the highest quality standards in our processes.
Our R&D department collaborates with the University of the Republic and receives support from the National Research and Innovation Agency of Uruguay (ANII). This partnership grants us access to a global network of university scientists, fostering innovation and knowledge exchange.
Our Products: Clone-to-Bottle Excellence
At the heart of our operation lies complete control over every stage of production. We do not use third-party extracts. Our commitment to quality and consistency is reflected in our comprehensive clone to-bottle approach:
Cloning and Cultivation
We begin with carefully selected genetic material, ensuring each plant meets our rigorous standards.
Harvesting and Processing
Our expert team harvests at peak potency, followed by meticulous drying to preserve essential compounds.
Extraction and Bottling
Using state-of-the-art extraction methods, we capture the full spectrum of beneficial compounds before bottling the final product. By managing the entire process in-house, we guarantee the purity and potency of every product.
We currently offer the following formulations:
1. CBD 2:1 THC / Full Spectrum
with doses of 22 mg/ml
CBD and 9 mg/ml THC.
2. CBD 1:1 THC / Full Spectrum
with doses of 27 mg/ml
CBD and 25 mg/ml THC.
GrüneLabs is a global Phytopharmaceutical company with operations in Uruguay, and Portugal.
+598 2291 4543
- Uruguay
Departamento de Canelones
- Portugal
Parque Industrial Gardunha Sul
6005-300 | Soalheira
Castelo Branco